TL;DR
Verification confirms that your device was built correctly according to defined requirements. Validation confirms that you built the right device for its intended users and environment. Both are essential not only for regulatory approval, but for ensuring patient safety, reducing development risk, and enabling successful commercialization. Weak execution leads to delays, rework, and regulatory scrutiny, while a strong V&V strategy accelerates development and builds confidence across stakeholders.
Setting the Stage: Why Verification and Validation Matter
In medical device development, few activities are as foundational and as frequently misunderstood as verification and validation, often referred to as V&V. While the terms are sometimes used interchangeably, they serve distinct and complementary purposes that ultimately determine whether a device is safe, effective, and ready for market.
At a regulatory level, V&V is not optional. Agencies such as the U.S. Food and Drug Administration (FDA), along with standards like ISO 13485, require structured verification and validation activities as part of design controls. These requirements ensure that devices meet defined specifications and perform as intended in real-world conditions. However, reducing V&V to a compliance exercise misses its broader impact. In practice, V&V is one of the most powerful tools available to medtech organizations for reducing risk, aligning cross-functional teams, and improving development efficiency. It influences design quality, manufacturability, clinical usability, and post-market performance.
When approached strategically, V&V becomes a unifying framework that connects engineering, quality, regulatory, and clinical teams around a shared definition of success. When treated as a late-stage checkbox activity, it often results in fragmented efforts, costly rework, and delays in regulatory approval. As devices become more complex, particularly with the integration of software, connectivity, and user-dependent workflows, the need for a structured and proactive V&V strategy becomes even more critical.
Verification: Confirming the Device Was Built Correctly
Verification answers a fundamental question: Does the device meet its design inputs? This phase focuses on generating objective evidence that design outputs, such as specifications, drawings, and software code, align with predefined requirements. Verification activities typically include bench testing, inspections, simulations, and engineering analyses.
Under FDA 21 CFR 820.30(f), manufacturers are required to confirm that design outputs meet design inputs. This requires well-defined protocols, clear acceptance criteria, and robust traceability linking each requirement to its corresponding verification activity. Effective verification begins long before testing is executed. It starts with the development of clear, complete, and testable requirements. Poorly defined requirements that are ambiguous, subjective, or not measurable often lead to verification gaps that are discovered late in development, when changes are more costly and time-consuming.
For example, a requirement stating that a device should be “easy to use” cannot be meaningfully verified without measurable criteria. As a result, teams may proceed with incomplete evidence, only to encounter issues later during validation or regulatory review. Verification becomes more complex in systems that integrate mechanical components, electronics, and software. Interdependencies between subsystems can create cascading effects, where a change in one area impacts performance in another. Without a structured verification strategy, these interactions can be difficult to fully assess.
Organizations that excel in verification take a proactive and risk-based approach. They align testing activities with identified risks, ensure early traceability between requirements and test cases, and continuously refine their strategy as the design evolves. At Pathway MedTech, we support teams by developing verification strategies that are both compliant and practical, integrating requirements development, risk management, and test planning to reduce rework and improve efficiency.
Ensuring the Device Meets User Needs
While verification focuses on specifications, validation addresses a different and equally critical question: Does the device fulfill its intended use in real-world conditions? Validation evaluates how the device performs in the hands of its intended users within its intended environment. This often includes simulated use testing, usability studies, human factors engineering, and, where appropriate, clinical evaluation.
FDA 21 CFR 820.30(g) requires that validation be conducted under actual or simulated use conditions, incorporating software validation and risk analysis. Standards such as IEC 62366 reinforce the importance of usability engineering in identifying and mitigating use-related risks.
A key distinction is that a device can successfully pass verification and still fail validation. This occurs when the design meets its specifications, but those specifications do not adequately reflect real-world use. For example, a surgical device may meet all mechanical and performance requirements during bench testing, yet prove difficult for clinicians to operate in a fast-paced clinical environment. A software interface may function correctly from a technical standpoint, but still lead to user confusion or error due to poor design.
These challenges highlight the importance of incorporating user needs early in development. Validation is most effective when it is not treated as a final checkpoint, but as an ongoing process that informs design decisions from the outset. Human factors play a critical role in validation. Even well-engineered devices can introduce risk if they do not align with how users think, behave, and interact with the system. Understanding user workflows, environments, and constraints is essential for designing meaningful validation studies.
Pathway MedTech works with clients to define validation strategies early in development, integrating user needs, clinical context, and regulatory expectations to ensure that validation activities produce meaningful and actionable insights.
The Relationship Between Verification and Validation
Verification and validation are distinct processes, but they are deeply interconnected. Together, they form the foundation of design assurance.
Verification ensures that the device meets its defined specifications. Validation ensures that those specifications were appropriate for achieving the intended use. A gap in either area can undermine the entire development effort. This relationship is reflected in both FDA design controls and ISO 13485, which require traceability from user needs through design inputs, design outputs, verification, and validation. Each stage builds upon the previous one, creating a structured chain of evidence that supports regulatory approval.
In practice, maintaining this traceability requires coordination across multiple functions. Engineering teams define requirements and design outputs, quality teams ensure compliance and documentation, regulatory teams interpret requirements, and clinical teams provide insight into real-world use. Organizations that treat V&V as an integrated system rather than separate activities are better equipped to manage complexity, reduce risk, and respond effectively to regulatory expectations.
At Pathway MedTech, we support this integration through structured design control processes, ensuring alignment across teams and maintaining clear traceability throughout the development lifecycle.
Common Challenges and Their Impact
Even experienced teams encounter recurring challenges when executing verification and validation.
Inadequate planning is one of the most common issues. When V&V activities are not defined early, testing becomes reactive rather than strategic. Teams may discover late in development that requirements are incomplete, inconsistent, or not testable, leading to redesign and repeated testing cycles. Documentation is another frequent challenge. Regulatory submissions require clear, traceable evidence linking requirements to verification and validation activities. Gaps or inconsistencies in documentation can result in delays, additional review cycles, or requests for further information from regulatory bodies.
Evolving requirements, particularly in software-driven devices, can create misalignment between design and testing. Without strong configuration management and traceability, it becomes difficult to ensure that all changes are properly verified and validated. Human factors are often underestimated. Devices that perform well in controlled testing environments may still introduce risk if they do not align with user workflows or expectations. This can lead to use errors, reduced adoption, or post-market issues.
The consequences of these challenges include delayed approvals, increased development costs, and potential risks to patient safety. Organizations that proactively address these issues benefit from more predictable timelines, smoother regulatory interactions, and stronger overall product performance. Pathway MedTech helps mitigate these risks by establishing structured planning processes, clear documentation practices, and alignment with regulatory standards from the outset.
Building a Scalable V&V Framework
As organizations grow and manage multiple development programs, V&V must evolve from a project-specific activity into a scalable and repeatable capability. A strong V&V framework includes standardized templates, defined governance structures, and integration with the organization’s quality management system. It also incorporates risk management principles such as those outlined in ISO 14971 to prioritize testing efforts and allocate resources effectively.
Scalability requires consistency, but it must also allow for flexibility. Different devices vary in complexity, risk classification, and regulatory pathways. An effective framework adapts to these variables while maintaining a consistent approach to documentation, traceability, and execution. Digital tools can enhance scalability by enabling better data management, traceability, and collaboration across teams. However, tools alone are not sufficient. Success depends on clearly defined processes, roles, and responsibilities.
Pathway MedTech works with organizations to build V&V frameworks that support both current development efforts and long-term growth, ensuring that processes remain efficient, compliant, and adaptable.
Final Perspective: From Requirement to Advantage
Verification and validation are often viewed through the lens of compliance. While regulatory adherence is essential, it represents only part of their value.
When executed effectively, V&V becomes a strategic advantage. It improves product quality, reduces development risk, and builds confidence with regulators, investors, and end users. It enables teams to identify and resolve issues earlier in the development process, when changes are less costly and more manageable.
In an industry where patient safety and regulatory rigor are paramount, this level of discipline is foundational. With the right strategy, tools, and expertise, verification and validation can shift from being perceived as a burden to becoming a core enabler of successful product development.
Pathway MedTech brings the experience and structure needed to navigate this complexity, helping organizations deliver safe, effective, and market-ready medical devices with confidence.
References
- U.S. Food and Drug Administration (FDA) https://www.fda.gov/medical-devices
- FDA 510(k) Program Guidance https://www.fda.gov/regulatory-information/search-fda-guidance-documents/510k-program-evaluating-substantial-equivalence
- FDA De Novo Classification Processhttps://www.fda.gov/medical-devices/premarket-submissions/de-novo-classification-request
- FDA Premarket Approval (PMA) Overviewhttps://www.fda.gov/medical-devices/premarket-submissions/premarket-approval-pma
- ISO 13485: Medical Devices Quality Management Systemshttps://www.iso.org/standard/59752.html
- ISO 14971: Risk Management for Medical Deviceshttps://www.iso.org/standard/72704.html
- IEC 60601: Medical Electrical Equipment Safetyhttps://www.iec.ch/dyn/www/f?p=103:85:0::::FSP_LANG_ID:25
- IEC 62304: Medical Device Software Lifecycle Processeshttps://www.iec.ch/dyn/www/f?p=103:85:0::::FSP_LANG_ID:25